Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
LB-100 | Small molecule | small cell lung carcinoma | Serine/threonine-protein phosphatase 5 inhibitor | 1.0 | Recruiting | ClinicalTrials |
LB-100 | Small molecule | cancer | Serine/threonine-protein phosphatase 5 inhibitor | 1.0 | Completed | ClinicalTrials |
LB-100 | Small molecule | myelodysplastic syndrome | Serine/threonine-protein phosphatase 5 inhibitor | 1.0 | Recruiting | ClinicalTrials |
LB-100 | Small molecule | glioblastoma multiforme | Serine/threonine-protein phosphatase 5 inhibitor | 2.0 | Recruiting | ClinicalTrials |
LB-100 | Small molecule | oligodendroglioma | Serine/threonine-protein phosphatase 5 inhibitor | 2.0 | Recruiting | ClinicalTrials |